SCHEMBL21362755

SCHEMBL21362755

C=CC(=C)c1cn(C)c(=O)cc1CNC(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.37
BAZ2B Q9UIF8 1/20 0.36
BAZ2A Q9UIF9 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
KDM4A O75164 1/20 0.35
HDAC10 Q969S8 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
NSD2 O96028 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33
GFER P55789 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
NAMPT P43490 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157341 0.81 KDM4E (0.40) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL20157285 0.78 HDAC10 (0.40) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL20157917 0.72 KDM4E (0.35) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL20157334 0.71 PRMT5 (0.48) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL21362444 0.70 PRMT5 (0.43) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL20157599 0.70 MAPT (0.38) KCNA5LMNAL3MBTL1RAF1BRAF
SCHEMBL13837691 0.69 NAMPT (0.47) KDM4ELMNAKDM4AHDAC10HDAC6
SCHEMBL21550130 0.69 KDM4E (0.42) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL20157810 0.68 BRD4 (0.46) KCNA5KDM4ELMNAKDM4AHDAC10
SCHEMBL13837417 0.68 BRD9 (0.47) BAZ2BBAZ2AKDM4ELMNAKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed